On July 1, 2019, Connecticut Governor Ned Lamont signed into law Public Act No. 19-115, “An Act Concerning Alzheimer’s Disease and Dementia Training and Best Practices” (PA 19-115). This legislation modifies the continuing medical education (CME) requirements for Connecticut-licensed physicians and the continuing education (CE) requirements for advanced practice registered nurses (APRNs).
Continue Reading Connecticut Enacts Law Modifying CME Requirements to Include Alzheimer’s Disease and Dementia Training
2019 Connecticut Legislative Update
Connecticut Enacts Law to Increase Access to Epinephrine Auto Injectors
By Robinson+Cole's Health Law Group on
Posted in 2019 Connecticut Legislative Update, Academic Medical Centers, Ambulance, Ambulatory Surgical Centers (ASC), Employment Law, Home Health Agencies, Hospice, Hospitals and Health Systems, Legislation, Long Term Care and Nursing Homes, Long Term Care Facilities, Medical Devices, Pharmaceuticals and Biologics, Pharmacies, Pharmacy Law, Physicians and Allied Health Professionals
On June 13, 2019, Connecticut Governor Ned Lamont signed into law Public Act No. 19-19 “An Act Concerning Epinephrine Auto Injectors” (PA 19-19), which went into effect on the same date.
This legislation expands access to epinephrine, which can be lifesaving when treating anaphylactic allergic reactions. PA 19-19 permits “authorized entities” to acquire and maintain a supply of epinephrine cartridge injectors, subject to certain conditions. With a few exceptions, authorized entities are for-profit or nonprofit entities or organizations that employ at least one “person with training.” …
Continue Reading Connecticut Enacts Law to Increase Access to Epinephrine Auto Injectors